# FFA-Induced Hypertension and Endothelial Dysfunction

> **NCT00589888** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 13 (actual)

## Conditions studied

- Endothelial Dysfunction
- Hypertension

## Interventions

- **DRUG:** Intralipid 20% @ 20cc/hour
- **DRUG:** Intralipid 20%@ 40cc/hour
- **DRUG:** Normal Saline
- **DIETARY_SUPPLEMENT:** 32-gram oral fat load
- **DIETARY_SUPPLEMENT:** 64-gram oral fat load

## Key facts

- **NCT ID:** NCT00589888
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-04
- **Final completion:** 2008-08
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2018-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00589888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00589888, "FFA-Induced Hypertension and Endothelial Dysfunction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00589888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*